Literature DB >> 1526869

Re-irradiation of pituitary adenoma.

R Schoenthaler1, N W Albright, W M Wara, T L Phillips, C B Wilson, D A Larson.   

Abstract

Fifteen patients initially irradiated for pituitary adenoma were subsequently treated with a second course of radiotherapy at the University of California at San Francisco between 1961 and 1989. The re-irradiation followed surgery in all but two cases. The median time to recurrence was 9 years (range 2-17) and median follow-up after the second course of radiotherapy was 10 years (range 1-30). The median initial radiation dose was 4084 cGy; that at recurrence was 4200 cGy. Local control has been maintained in 12 patients. One failed locally with a benign adenoma that was surgically salvaged. Two developed pituitary carcinomas which were poorly controlled. Of the patients who presented with visual abnormalities at the time of recurrence, 50% improved and the remainder stabilized after re-irradiation. There are no long-term visual complications. Hypopituitarism was present in nine patients prior to the second course of radiotherapy and developed in the remaining six patients after re-irradiation. Temporal lobe injury was seen in two patients. Careful analysis of each patient's pituitary and temporal lobe doses, intervals between treatments, treatment volume, neurets, relative decay factors, absolute decay factors, TDF and modified LQF values, and dose-volume relationships, revealed no correlation with complication or likelihood of local control. Repeat radiotherapy for recurrent pituitary adenoma with the doses used in these patients appears to carry acceptable risk with good local control.

Entities:  

Mesh:

Year:  1992        PMID: 1526869     DOI: 10.1016/0360-3016(92)90686-c

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  The incidence of cerebrovascular accidents and second brain tumors in patients with pituitary adenoma: a population-based study.

Authors:  Paul D Brown; Miran Blanchard; Krishan Jethwa; Kelly D Flemming; Cerise A Brown; Robert W Kline; Debra J Jacobson; Jennifer St Sauver; Bruce E Pollock; Yolanda I Garces; Scott L Stafford; Michael J Link; Dana Erickson; Robert L Foote; Nadia N I Laack
Journal:  Neurooncol Pract       Date:  2014-03

Review 2.  Focal radiation therapy for patients with persistent/recurrent pituitary adenoma, despite previous radiotherapy.

Authors:  Albert A Edwards; Francesca M Swords; P N Plowman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

3.  Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.

Authors:  Jonathan Verma; Ian E McCutcheon; Steven G Waguespack; Anita Mahajan
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

4.  Effects of radiotherapy on pituitary corticotroph macrotumors in dogs: a retrospective study of 12 cases.

Authors:  Pauline de Fornel; Françoise Delisle; Patrick Devauchelle; Dan Rosenberg
Journal:  Can Vet J       Date:  2007-05       Impact factor: 1.008

Review 5.  Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review.

Authors:  Odelia Cooper; Vivien Bonert; Ning-Ai Liu; Adam N Mamelak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-15       Impact factor: 5.555

6.  Long-term management and postmortem examination in a diabetic cat with acromegaly treated with two courses of radiation therapy.

Authors:  Harumi Sawada; Akihiro Mori; Masaki Michishita; Hitomi Oda; Toshinori Sako
Journal:  J Vet Med Sci       Date:  2018-11-16       Impact factor: 1.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.